From: Risk factors for overuse injuries in a cohort of elite Swedish track and field athletes
 | Group | n | p | rpb | m | SD |
---|---|---|---|---|---|---|
Movement | ||||||
 HADROM_R [°] | Inj | 15 | .16 | .24 | 4.68 | 2.38 |
No | 66 | Â | Â | 5.80 | 2.58 | |
 HADROM_L [°] | Inj | 15 | .13 | .25 | 4.19 | 2.01 |
No | 66 | Â | Â | 5.21 | 2.44 | |
 KFVEL_R [°/s] | Inj | 15 | .08 | .29 | 257.82 | 41.53 |
No | 66 | Â | Â | 360.59 | 161.28 | |
 KFVEL_L [°/s] | Inj | 15 | .03* | .37 | 266.14 | 42.50 |
No | 66 | Â | Â | 367.97 | 152.16 | |
 AEV_R [°] | Inj | 15 | .70 | −.07 | 14.86 | 5.61 |
No | 66 | Â | Â | 15.78 | 7.66 | |
 AEV_L [°] | Inj | 15 | .53 | −.11 | 15.24 | 5.06 |
No | 66 | Â | Â | 15.67 | 7.51 | |
 AEVVEL_R [°/s] | Inj | 15 | .88 | −.03 | 245.12 | 88.32 |
No | 66 | Â | Â | 266.10 | 133.35 | |
 AEVVEL_L [°/s] | Inj | 15 | .64 | −.08 | 250.26 | 84.70 |
No | 66 | Â | Â | 262.72 | 134.95 | |
Clinical | ||||||
 RFFLEX_R [°] | Inj | 17 | .30 | .16 | 140.77 | 8.48 |
No | 73 | Â | Â | 140.74 | 15.62 | |
 RFFLEX_L [°] | Inj | 17 | .82 | .04 | 148.94 | 5.80 |
No | 73 | Â | Â | 149.25 | 10.11 | |
 ILFLEX_R [°] | Inj | 17 | .17 | −.21 | 108.77 | 11.46 |
No | 78 | Â | Â | 107.40 | 10.66 | |
 ILFLEX_L [°] | Inj | 17 | .15 | −.23 | 111.25 | 8.61 |
No | 78 | Â | Â | 110.65 | 8.65 | |
Strength | ||||||
 HAB:HAD [Nm/kg] | Inj | 16 | .25 | .15 | 0.76 | 0.08 |
No | 79 | Â | Â | 0.82 | 0.21 | |
 H:Q_R [Nm/kg] | Inj | 17 | .62 | .08 | 0.79 | 0.15 |
No | 77 | Â | Â | 0.84 | 0.16 | |
 H:Q_L [Nm/kg] | Inj | 17 | .84 | .03 | 0.80 | 0.12 |
No | 77 | Â | Â | 0.83 | 0.15 |